1. TP036/#426 Uplift (ENGOT-OV67/GOG-3048) a pivotal cohort of the XMT-1536–1 trial of upifitamab rilsodotin (XMT-1536; UPRI), a NAPI2B-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer. (4th December 2022) Authors: Richardson, Debra; Perez Fidalgo, Jose Alejandro; Gonzalez-Martin, Antonio; Oaknin, Ana; Hamilton, Erika; Hays, John; Pothuri, Bhavana; Papadopoulos, Kyriakos; Taylor, Sara; Huang, Marilyn; Lee, Yeh-Chen; Krivak, Thomas; Moreno-Garcia, Victor; Calvo, Emiliano; Randall, Leslie; Starks, David; Ross... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗